Authors
Loading...
Clinical entity identified differentiates mild cognitive impairment from healthy controls and very mild AD, suggesting targeted treatments.
Petersen et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: